More
    Guided Solutions - Connecting Talent With Innovation/div>

    GS MedTech Funding Tracker – Brainomix, Trinity, and more

    This week’s MedTech tracker showcases the intersection of AI and neurotechnology, with investors backing companies advancing stroke imaging, neurotherapeutics, wearable biosensors, and neuromuscular interfaces. Capital is flowing toward U.S. expansion, regulatory milestones, and platform-scale...

    GS MedTech Funding Tracker – Brainomix, Trinity, and more

    This week’s MedTech tracker showcases the intersection of AI and neurotechnology, with investors backing companies advancing stroke imaging, neurotherapeutics, wearable biosensors, and neuromuscular interfaces....

    TECLens begins first-in-human trial for qCXL vision correction technology

    TECLens has commenced the first-in-human clinical trial assessing its quantitative corneal crosslinking (qCXL) technology for non-invasive refractive vision correction, administering treatment to the initial...

    Blue Arbor adds $5M in Ottobock partnership to advance neuromuscular interface

    Blue Arbor Technologies announced a partnership with Ottobock, anchored by a $5 million investment. The investment positions Ottobock — also the leading shareholder in Onward...

    Trinity Biotech raises $25M to advance CGM+ system

    Trinity Biotech announced that it entered into a $25 million Standby Equity Purchase Agreement (SEPA). The agreement with an affiliate of financing partner Yorkville Advisors...
    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    Finance

    Funding

    Clinical Trials

    TECLens begins first-in-human trial for qCXL vision correction technology

    TECLens has commenced the first-in-human clinical trial assessing its quantitative corneal crosslinking (qCXL) technology for non-invasive refractive vision correction, administering treatment to the initial...

    VESTECK announces the results for SUTURE-TIGHT Endovascular Repair Catheter

    VESTECK announced that implanting clinicians will present two-year follow-up data from the company’s first-in-human experience with the SUTURE-TIGHT™ Endovascular Catheter System, an adjunctive fixation...

    Kandu trial highlights positive outcomes with IpsiHand BCI system

    Kandu Health announced positive results from the first randomized controlled trial of its brain-computer interface (BCI) therapy. The trial evaluated its FDA-cleared, non-invasive IpsiHand BCI...

    CorTec announces successful second human implantation of its BCI system

    CorTec GmbH, a pioneer in active implantable medical technologies, announced the successful second implantation of its proprietary BrainComputer Interface (BCI) system, the Brain Interchange,...

    Innovation

    Regulatory Approvals

    GS MedTech Funding Tracker – Brainomix, Trinity, and more

    This week’s MedTech tracker showcases the intersection of AI and neurotechnology, with investors backing companies advancing stroke imaging, neurotherapeutics, wearable biosensors, and neuromuscular interfaces....

    TECLens begins first-in-human trial for qCXL vision correction technology

    TECLens has commenced the first-in-human clinical trial assessing its quantitative corneal crosslinking (qCXL) technology for non-invasive refractive vision correction, administering treatment to the initial...

    Blue Arbor adds $5M in Ottobock partnership to advance neuromuscular interface

    Blue Arbor Technologies announced a partnership with Ottobock, anchored by a $5 million investment. The investment positions Ottobock — also the leading shareholder in Onward...

    Trinity Biotech raises $25M to advance CGM+ system

    Trinity Biotech announced that it entered into a $25 million Standby Equity Purchase Agreement (SEPA). The agreement with an affiliate of financing partner Yorkville Advisors...

    M&A

    Archives

    Latest articles